| Literature DB >> 36092804 |
Haúla F Haider1,2, Diogo Ribeiro2,3, Sara F Ribeiro1, Nuno Trigueiros4, Helena Caria5,6, Luís Borrego3,7, Iola Pinto8,9, Ana L Papoila3, Derek J Hoare10, João Paço1.
Abstract
Tinnitus is a phantom sound perceived in the absence of external acoustic stimulation. It is described in a variety of ways (e.g., buzzing, ringing, and roaring) and can be a single sound or a combination of different sounds. Our study evaluated associations between audiological parameters and the presence or severity of tinnitus, to improve tinnitus diagnosis, treatment, and prognosis. Our sample included 122 older participants (63 women and 59 men), aged 55-75 years from the Portuguese population, with or without sensory presbycusis and with or without tinnitus. All participants underwent a clinical evaluation through a structured interview, Ear, Nose, and Throat observation, and audiological evaluation (standard and extended audiometry, psychoacoustic tinnitus evaluation, auditory brainstem responses, and distortion product otoacoustic emissions). The Tinnitus Handicap Inventory was used to measure tinnitus symptom severity. Our data confirmed that the odds of developing tinnitus were significantly higher in the presence of noise exposure and hearing loss. Also, participants who had abrupt tinnitus onset and moderate or severe hyperacusis featured higher odds of at least moderate tinnitus. However, it was in the ABR that we obtained the most exciting and promising results, namely, in wave I, which was the common denominator in all findings. The increase in wave I amplitude is a protective factor to the odds of having tinnitus. Concerning the severity of tinnitus, the logistic regression model showed that for each unit of increase in the mean ratio V/I of ABR, the likelihood of having at least moderate tinnitus was 10% higher. Advancing knowledge concerning potential tinnitus audiological biomarkers can be crucial for the adequate diagnosis and treatment of tinnitus.Entities:
Keywords: audiological biomarkers; auditory brainstem response; distortion product otoacoustic emissions; hearing loss; pure tone average; tinnitus
Year: 2022 PMID: 36092804 PMCID: PMC9449802 DOI: 10.3389/fnagi.2022.933117
Source DB: PubMed Journal: Front Aging Neurosci ISSN: 1663-4365 Impact factor: 5.702
Distribution of the participants of the sample by four subgroups.
| Subgroup | Audiological characteristic | Gender (n) | n (%) | Age | |
| Male | Female | ||||
| 1 | PTA ≤ 20 without Tinnitus | 7 | 15 | 22 (18.0) | 63.0 (59.0; 68.3) |
| 2 | PTA ≤ 20 with Tinnitus | 15 | 27 | 42 (34.4) | 63.0 (59.0; 68.3) |
| 3 | PTA > 20 without Tinnitus | 6 | 2 | 8 (6.6) | 63.0 (59.0; 68.3) |
| 4 | PTA > 20 with Tinnitus | 31 | 19 | 50 (41.0) | 63.0 (59.0; 68.3) |
|
| 59 | 63 | 122 | ||
PTA, Pure tone average. *Data are summarized as median (25th percentile; 75th percentile).
PTA and “HF” PTA according to tinnitus presence.
| Variables | All participants ( | With tinnitus ( | Without tinnitus ( | |
| Mean PTA (dB) | 20.0 (14.8; 28.3) | 21.6 (16.4; 29.4) | 16.9 (12.3; 21.4) | 0.009 |
| Mean “HF” PTA (dB) | 35.0 (23.3; 47.7) | 37.9 (28.8; 48.3) | 25.4 (18.3; 34.2) | 0.001 |
Data are summarized as median (25th percentile; 75th percentile); PTA, Pure tone average, “HF” PTA, “High frequency” pure-tone average; *p-values were obtained by univariable logistic regression models.
Comparison of auditory brainstem response in the four subgroups.
| Auditory brainstem response | All participants ( | PTA ≤ 20 without tinnitus ( | PTA ≤ 20 with tinnitus ( | PTA > 20 without tinnitus ( | PTA > 20 with tinnitus ( | |
| Wave I Latency (ms) | 2.0 (1.9; 2.1) | 2.0 (1.9; 2.1) | 2.1 (1.9; 2.2) | 2.0 (1.9; 2.2) | 2.0 (1.9; 2.2) | 0.647 |
| Wave III Latency (ms) | 4.2 (4.0; 4.4) | 4.1 (3.9; 4.3) | 4.2 (4.0; 4.3) | 4.1 (3.3; 4.3) | 4.3 (4.1; 4.5) | 0.007(a) |
| Wave V Latency (ms) | 6.1 (6.0; 6.3) | 6.1 (5.8; 6.2) | 6.1 (5.9; 6.2) | 6.0 (5.4; 6.4) | 6.3 (6.1; 6.4) | 0.001(b) |
| IWI I-III (ms) | 2.2 (2.1; 2.3) | 2.2 (2.2; 2.4) | 2.1 (2.0; 2.2) | 2.2 (2.0; 2.4) | 2.2 (2.1; 2.4) | 0.011(c) |
| IWI III-V (ms) | 1.9 (1.8; 2.0) | 1.9 (1.8; 2.0) | 1.9 (1.8; 2.0) | 2.0 (1.9; 2.1) | 2.0 (1.8; 2.1) | 0.197 |
| IWI I-V (ms) | 4.1 (4.0; 4.3) | 4.1 (4.0; 4.3) | 4.0 (3.1; 4.2) | 4.2 (4.0; 4.4) | 4.2 (4.1; 4.3) | 0.003(d) |
| Amplitude wave I (μV) | 0.07 (0.05; 0.11) | 0.09 (0.05; 0.15) | 0.09 (0.05; 0.11) | 0.07 (0.05; 0.11) | 0.06 (0.03; 0.09) | 0.007(e) |
| Amplitude wave V (μV) | 0.2 (0.1; 0.3) | 0.22 (0.15; 0.30) | 0.24 (0.16; 0.29) | 0.15 (0.11; 0.19) | 0.14 (0.08; 0.18) | < 0.001 (f) |
| V/I amplitude ratio (μV) | 2.9 (1.8; 6.6) | 2.3 (1.7; 3.8) | 3.2 (2.3; 7.7) | 2.5 (2.0; 7.7) | 3.0 (1.8; 7.8) | 0.358 |
Data are summarized as median (25th percentile; 75th percentile); IWI, Interwave latency interval, PTA, Pure tone average; *p-values were obtained by Kruskal–Wallis test.
(a) p = 0.031 for the groups PTA ≤ 20 with tinnitus and PTA > 20 with tinnitus.
(b) p = 0.003 for the groups PTA ≤ 20 with tinnitus and PTA > 20 with tinnitus; p = 0.016 for the groups and PTA > 20 with tinnitus and PTA ≤ 20 without tinnitus.
(c) p = 0.036 for the groups PTA ≤ 20 with tinnitus and PTA > 20 with tinnitus; p = 0.022 for the groups PTA ≤ 20 with tinnitus and PTA ≤ 20 without tinnitus. (d) p = 0.002 for the groups PTA ≤ 20 with tinnitus and PTA > 20 with tinnitus.
(e) p = 0.012 for the groups PTA ≤ 20 without tinnitus and PTA > 20 with tinnitus.
(f) p < 0.001 for the groups PTA ≤ 20 with tinnitus and PTA > 20 with tinnitus; p < 0.001 for the groups PTA > 20 with tinnitus and PTA ≤ 20 without tinnitus.
FIGURE 1Interpeak latency intervals I-III, III-V, and I-V for the four subgroups. Mean values with error bars: column height represents the mean, and the bars of each column show the standard deviation.
Comparison of auditory brainstem response between participants with and without tinnitus.
| Auditory brainstem response | All participants ( | With tinnitus ( | Without tinnitus ( | |
| Wave I Latency (ms) | 2.0 (1.9; 2.1) | 2.0 (1.9; 2.2) | 2.0 (1.9; 2.1) | 0.115 |
| Wave III Latency (ms) | 4.2 (4.0; 4.4) | 4.2 (4.1; 4.4) | 4.1 (3.5; 4.3) | 0.695 |
| Wave V Latency (ms) | 6.1 (6.0; 6.3) | 6.2 (6.0; 6.3) | 6.1 (5.5; 6.3) | 0.968 |
| IWI I-III (ms) | 2.2 (2.1; 2.3) | 2.2 (2.1; 2.3) | 2.2 (2.1; 2.4) | 0.197 |
| IWI III-V (ms) | 1.9 (1.8; 2.0) | 1.9 (1.8; 2.0) | 2.0 (1.9; 2.0) | 0.597 |
| IWI I-V (ms) | 4.1 (4.0; 4.3) | 4.1 (4.0; 4.3) | 4.2 (4.0; 4.3) | 0.139 |
| Amplitude wave I (μV) | 0.07 (0.05; 0.11) | 0.07 (0.04; 0.10) | 0.08 (0.05; 0.15) | 0.033 |
| Amplitude wave V (μV) | 0.2 (0.1; 0.3) | 0.2 (0.1; 0.2) | 0.2 (0.1; 0.3) | 0.178 |
| V/I amplitude ratio (μV) | 2.9 (1.8; 6.6) | 3.2 (1.9; 7.7) | 2.4 (1.7; 4.3) | 0.340 |
Data are summarized as median (25th percentile; 75th percentile); IWI, Interwave latency interval; *p-values were obtained by the Mann–Whitney U test.
FIGURE 2Amplitude of waves I and V in participants with and without tinnitus. Mean values with error bars: column height represents the mean, and the bars of each column show the standard deviation.
FIGURE 3Mean of distortion product otoacoustic emissions in participants with and without tinnitus.
Comparison of distortion product otoacoustic emissions in participants with and without tinnitus.
| Distortion product otoacoustic emissions (Hz) | All participants ( | With tinnitus ( | Without tinnitus ( | |
| Mean 500–8000 | 122 | 0.014 | ||
| 500 | 69 | n = 54 9.7 (7.9; 12.4) | n = 15 9.5 (7.7;19.8) | 0.432 |
| 750 | 104 | 0.247 | ||
| 1000 | 112 | 0.052 | ||
| 1500 | 117 | 0.394 | ||
| 2000 | 115 | 0.515 | ||
| 2500 | 110 | 0.402 | ||
| 3000 | 115 | 0.036 | ||
| 3200 | 105 | 0.703 | ||
| 3500 | 107 | 0.049 | ||
| 4000 | 102 | n = 76 13.0 (10.0;17.7) | 0.013 | |
| 4500 | 101 | 0.017 | ||
| 5000 | 100 | 0.144 | ||
| 5500 | 90 | 0.014 | ||
| 6000 | 100 | 0.047 | ||
| 7000 | 103 | 0.091 | ||
| 8000 | 90 | 0.428 |
Data are summarized as median (25th percentile; 75th percentile). Mean = mean of DPOAE frequencies from 500 to 8,000 Hz. *p-values were obtained by the Mann–Whitney U test.
Clinical characterization of tinnitus sample.
| Clinical variables | Participants with tinnitus ( |
| Tinnitus duration (in years) | 5.0 (2.0; 10.0) |
| Intensity of tinnitus (scale 1–10) | 3.0 (2.0; 4.0) |
| Constant | 80 (88.9) |
| Intermittent | 6 (6.7) |
| Pulsatile | 4 (4.4) |
| Gradual | 45 (71.4) |
| Abrupt | 18 (28.6) |
| Yes | 54 (59.3) |
| No | 37 (40.7) |
| Yes | 45 (50.6) |
| No | 44 (49.4) |
|
| |
| Yes | 25 (29.4) |
|
| |
| Yes | 35 (41.2) |
|
| |
| Yes | 49 (53.3) |
| Non exposed | 56 (61.5) |
| Exposed without protection | 31 (34.1) |
| Exposed with protection | 4 (4.4) |
Continuous variables are summarized as median (25th percentile; 75th percentile) and categorical variables as n (%).
Psychoacoustic tinnitus assessment.
| Audiological measurements | Participants with tinnitus ( |
| Pitch ( | 4000 Hz (2000 Hz; 8000 Hz) |
| Loudness ( | 0 dB (0 dB; 5.0 dB) |
| Central | 44 (52.4) |
| Right | 15 (17.9) |
| Left | 25 (29.8) |
| Pure tone | 49 (59.0) |
| Narrow band noise | 34 (41.0) |
| Congruent | 17 (20.2) |
| Convergent | 40 (47.6) |
| Divergent | 1 (1.2) |
| Distant | 25 (29.8) |
| Persistent | 1 (1.2) |
| Negative | 36 (43.9) |
| Partial | 30 (36.6) |
| Complete | 13 (15.9) |
| Rebound effect | 3 (3.7) |
Data are summarized as n (%).
DPOAE results in participants with tinnitus, according to noise exposure conditions.
| Distortion product otoacoustic emissions | Submitted to noise exposure ( | Non-submitted to noise exposure ( | |
| Mean 500–8000 | 12.2 (10.7; 13.3) | 14.2 (11.5; 17.1) | 0.040 |
Data are summarized as median (25th percentile; 75th percentile); Mean = mean of DPOAE frequencies from 500 to 8,000 Hz. *p-value was obtained by the Mann–Whitney U test.
Univariable analysis: logistic regression model for the presence of tinnitus.
| Variable |
| (95%CI) | |
| Noise exposure | 3.96 | 0.036 | (1.09, 14.36) |
| Mean PTA | 1.08 | 0.009 | (1.02, 1.14) |
| Hearing Loss | 3.87 | 0.014 | (1.32, 11.39) |
| Mean “HF” PTA | 1.07 | 0.001 | (1.03, 1.11) |
| DPOAE mean 500–8000 | 0.86 | 0.023 | (0.75, 1.11) |
| Amplitude wave I | 0.404 | 0.016 | (0.193, 0.844) |
(1) odds of having tinnitus for every 10 units of increase of the amplitude wave I; CI confidence interval; PTA = Pure tone average; “HF” PTA = “High frequency” pure-tone average; DPOAE = Distortion product otoacoustic emissions; Mean = mean of DPOAE frequencies from 500 to 8,000 Hz.
Univariable analysis: patient characteristics by group (high versus low THI score).
| Variables | All participants ( | Low THI score ( | High THI score ( | |
| Gradual | 45 (71.4) | 32 (82.1) | 13 (54.2) | 0.017 |
| Abrupt | 18 (28.6) | 7 (17.9) | 11 (45.8) | |
| Negative | 66 (77.6) | 39 (76.5) | 27 (79.4) | 0.03 |
| Moderate | 5 (5.9) | 2 (3.9) | 3 (8.8) | |
| Light | 11 (12.9) | 10 (19.6) | 1 (2.9) | |
| Severe | 3 (3.5) | 0 (0) | 3 (8.8) | |
| Negative | 36 (43.9) | 23 (46.9) | 13 (39.4) | 0.034 |
| Partial | 30 (36.6) | 13 (26.5) | 17 (51.5) | |
| Complete | 13 (15.9) | 11 (22.4) | 2(6.1) | |
| Rebound Effect | 3 (3.7) | 2 (4.1) | 1 (3.0) |
(1) Chi-square test p-value; (2) Fisher’s exact test p-values.
Univariable analysis logistic regression model: tinnitus characteristics by group (higher versus lower THI score).
| Variables | ||
|
| 3.87 (1.23, 12.17) | |
| Gradual | ||
| Abrupt | ||
|
| 5.25 | |
| Negative + Light | ||
| Moderate + Severe |
odds ratio estimate. (1) reference category is light or negative hyperacusis.